Inclusion levels of sweet potato root meal in the diet of broilers I. Effect on performance, organ weights, and carcass quality

by Beckford, R. C., Bartlett, J. R.
Published 2015

Analysis of cAMP RI alpha mRNA expression in breast cancer: evaluation of quantitative polymerase chain reaction for routine use.

by Bartlett, J. M., Hulme, M. J., Miller, W. R.
Published 1996

Stability and change

by Bartlett, J., Tywoniak, Stephane, Cebon, P., Lok, J., Prichard, C., Wilcox, T.
Published 2011

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

by Bartlett, J. M., Watters, A. D., Ballantyne, S. A., Going, J. J., Grigor, K. M., Cooke, T. G.
Published 1998

Chromosome instability and benefit from adjuvant anthracyclines in breast cancer

by Munro, A F, Twelves, C, Thomas, J S, Cameron, D A, Bartlett, J MS
Published 2012

Falls in people prior to undergoing total hip or total knee replacement surgery: Frequency and associated factors

by Hill, Keith, Wee, E., Margelis, S., Menz, H., Bartlett, J., Bergman, N., McMahon, S., Hare, D., Levinger, P.
Published 2016

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.

by Bartlett, J. M., Rabiasz, G. J., Scott, W. N., Langdon, S. P., Smyth, J. F., Miller, W. R.
Published 1992

Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

by MacCallum, J., Bartlett, J. M., Thompson, A. M., Keen, J. C., Dixon, J. M., Miller, W. R.
Published 1994

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.

by MacCallum, J., Keen, J. C., Bartlett, J. M., Thompson, A. M., Dixon, J. M., Miller, W. R.
Published 1996

Development and validation of a questionnaire assessing discrepancy between patients’ pre-surgery expectations and abilities and post-surgical outcomes following knee replacement s...

by Levinger, P., Diamond, N., Menz, H., Wee, E., Margelis, S., Stewart, A., Bartlett, J., Bergman, N., McMahon, S., Hare, D., Hill, Keith
Published 2014

Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.

by Rabiasz, G. J., Langdon, S. P., Bartlett, J. M., Crew, A. J., Miller, E. P., Scott, W. N., Smyth, J. F., Miller, W. R.
Published 1992

Passive and post-exercise cold-water immersion augments PGC-1α and VEGF expression in human skeletal muscle

by Joo, C. H., Allan, R., Drust, B., Close, G. L., Jeong, T. S., Bartlett, J. D., Mawhinney, C., Louhelainen, J., Morton, J. P., Gregson, Warren
Published 2016

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals

by Paterson, R W, Bartlett, J W, Blennow, K, Fox, N C, Shaw, L M, Trojanowski, J Q, Zetterberg, H, Schott, J M
Published 2014

A framework for biobank sustainability

by Watson, P., Nussbeck, S., Carter, C., O'Donoghue, S., Cheah, S., Matzke, L., Barnes, R., Bartlett, J., Carpenter, J., Grizzle, W., Johnston, R., Mes-Masson, A., Murphy, L., Sexton, K., Shepherd, L., Simeon-Dubach, D., Zeps, Nikolajs, Schacter, B.
Published 2014

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.

by Bartlett, J. M., Langdon, S. P., Simpson, B. J., Stewart, M., Katsaros, D., Sismondi, P., Love, S., Scott, W. N., Williams, A. R., Lessells, A. M., Macleod, K. G., Smyth, J. F., Miller, W. R.
Published 1996

PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer

by Vidal, A. C., Henry, N. M., Murphy, S. K., Oneko, O., Nye, M., Bartlett, J. A., Overcash, F., Huang, Z., Wang, F., Mlay, P., Obure, J., Smith, J., Vasquez, B., Swai, B., Hernandez, B., Hoyo, C.
Published 2013

TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial

by Bartlett, J M S, Nielsen, T O, Gao, D, Gelmon, K A, Quintayo, M A, Starczynski, J, Han, L, Burnell, M J, Levine, M N, Chen, B E, Shepherd, L E, Chapman, J W
Published 2015

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

by Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Published 2013

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

by Stephen, J, Murray, G, Cameron, D A, Thomas, J, Kunkler, I H, Jack, W, Kerr, G R, Piper, T, Brookes, C L, Rea, D W, van de Velde, C J H, Hasenburg, A, Markopoulos, C, Dirix, L, Seynaeve, C, Bartlett, J M S
Published 2014

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy:...

by Engels, C. C., Charehbili, A., van de Velde, C. J. H., Bastiaannet, E., Sajet, A., Putter, H., van Vliet, E. A., van Vlierberghe, R. L. P., Smit, V. T. H. B. M., Bartlett, J. M. S., Seynaeve, C., Liefers, G. J., Kuppen, P. J. K.
Published 2015